Efficacy of recombinant adenovirus expressing a fusion gene from GM-CSF and Epstein-Barr virus LMP2A in a mouse tumor model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of recombinant adenovirus expressing a fusion gene from GM-CSF and Epstein-Barr virus LMP2A in a mouse tumor model

Published:2017-10-03 Issue:10 Volume:13 Page:2260-2268
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Xue Qingjie¹²,Li Xiuzhen¹,Yang Chunqing²,Ji Bingyuan²,Li Yunqing¹,Yan Yingchun³,Yang Xinxin⁴,Wang Chunmei²,Chen Ting¹

Affiliation:

1. Department of Pathogenic Biology, Jining Medical University , Jining, Shandong, China

2. Neurobiology Institute, Jining Medical University , Jining, Shandong, China

3. School of Mental Health, Jining Medical University , Shandong, China

4. School of Clinical College, Jining Medical University , Shandong, China

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2017.1356521

Reference17 articles.

1. Epstein–Barr virus latent antigens EBNA3C and EBNA1 modulate epithelial to mesenchymal transition of cancer cells associated with tumor metastasis

2. Alternate replication in B cells and epithelial cells switches tropism of Epstein–Barr virus

3. Epstein–Barr virus latent membrane protein 1 represses p53-mediated DNA repair and transcriptional activity

4. The Development of Prophylactic and Therapeutic EBV Vaccines

5. Epstein-Barr Virus LMP2A Interferes with Global Transcription Factor Regulation When Expressed during B-Lymphocyte Development

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress of Oncolytic Virus;Journal of Biomedical Nanotechnology;2024-10-01

2. Comprehensive Analysis of Epstein-Barr Virus LMP2A-Specific CD8⁺ and CD4⁺ T Cell Responses Restricted to Each HLA Class I and II Allotype Within an Individual;Immune Network;2023

3. Oncolytic viral vectors in the era of diversified cancer therapy: from preclinical to clinical;Clinical and Translational Oncology;2022-05-25

4. EB virus-positive tumors are inhibited by rBCG expressing hGM-CSF and LMP2A;Human Vaccines & Immunotherapeutics;2019-10-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3